SPL
ROIV icon

Superior Planning, LLC’s Roivant Sciences ROIV Stock Holding History

Superior Planning, LLC’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.38K Buy
+229
New +$8.3K ﹤0.01% 994

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Patient Square Capital
Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Superior Planning, LLC's ROIV Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Roivant Sciences (ROIV) in Q3 2026: 229 shares worth $8.38K. The stake represents ﹤0.01% of the portfolio and ranks #994 among its holdings.

325 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Superior Planning, LLC held 229 shares of Roivant Sciences worth $8.38K as of Q3 2026.
  • Roivant Sciences was a new Superior Planning, LLC position in Q3 2026.
  • Roivant Sciences made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #994 holding.
  • 325 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.